PBF509, an Adenosine A(2A) Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders

Adenosine A(2A) receptor (A(2A)R) antagonists have emerged as complementary non-dopaminergic drugs to alleviate Parkinson’s disease (PD) symptomatology. Here, we characterize a novel non-xhantine non-furan A(2A)R antagonist, PBF509, as a potential pro-dopaminergic drug for PD management. First, PBF5...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez, Fabiana, Taura, Jaume, Camacho, Juan, López-Cano, Marc, Fernández-Dueñas, Víctor, Castro, Naomi, Castro, Julio, Ciruela, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202948/
https://www.ncbi.nlm.nih.gov/pubmed/30405415
http://dx.doi.org/10.3389/fphar.2018.01200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202948/
https://www.ncbi.nlm.nih.gov/pubmed/30405415
http://dx.doi.org/10.3389/fphar.2018.01200

Ejemplares similares